Encore Medical to Present at Jefferies Life Sciences Conference on Wednesday, June 28, 2006
21 June 2006 - 10:30PM
PR Newswire (US)
AUSTIN, Texas, June 21 /PRNewswire-FirstCall/ -- Encore Medical
Corporation (NASDAQ:ENMC) will present at the Jefferies Life
Sciences Conference in New York at the Mandarin Oriental Hotel on
Wednesday, June 28, 2006. Kenneth W. Davidson, Chairman and Chief
Executive Officer and William W. Burke, Executive Vice President
and Chief Financial Officer, will present at 8:00 a.m. Eastern
time. The presentation will provide an overview of Encore's
products, market opportunities and competitive position. A live
audio webcast of the presentation will be accessible through Encore
Medical Corporation's web site at http://www.encoremed.com/ . The
webcast will be available for two weeks following the presentation.
Encore Medical Corporation is a diversified orthopedic device
company that develops, manufactures and distributes a comprehensive
range of high quality orthopedic devices used by orthopedic
surgeons, physicians, therapists, athletic trainers and other
healthcare professionals to treat patients with musculoskeletal
conditions resulting from degenerative diseases, deformities,
traumatic events and sports-related injuries. Through its
Orthopedic Rehabilitation Division, Encore is a leading distributor
of electrical stimulation and other orthopedic products used for
pain management, orthopedic rehabilitation, physical therapy,
fitness and sport performance enhancement. Encore's Surgical
Implant Division offers a comprehensive suite of reconstructive
joint products and spinal implants. For more information, visit
http://www.encoremed.com/ . Contact: William W. Burke, Executive
Vice President - Chief Financial Officer (512) 832-9500 Media:
Davis Henley, Vice President - Business Development (512) 832-9500
Except for the historical information contained herein, the matters
discussed are forward-looking statements made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act
of 1995. These statements involve risks and uncertainties, such as
the completion of this transaction and the use of proceeds
therefrom, the timely availability of new products, the impacts of
competitive products and pricing, the ability to continue to obtain
long-term financing, and other risks and uncertainties set forth in
the Company's filings with the Securities and Exchange Commission.
These risks and uncertainties could cause actual results to differ
materially from any forward-looking statements made herein.
DATASOURCE: Encore Medical Corporation CONTACT: William W. Burke,
Executive Vice President - Chief Financial Officer,
+1-512-832-9500, or , or media, Davis Henley, Vice President -
Business Development, +1-512-832-9500, or , both of Encore Medical
Corporation Web site: http://www.encoremed.com/
Copyright
Encore Medical (NASDAQ:ENMC)
Historical Stock Chart
From May 2024 to Jun 2024
Encore Medical (NASDAQ:ENMC)
Historical Stock Chart
From Jun 2023 to Jun 2024
Real-Time news about Encore Medical (NASDAQ): 0 recent articles
More Encore Medical (MM) News Articles